Clinical Chemistry
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
 QUICK SEARCH:   [advanced]


     


Clinical Chemistry 0: clinchem.2005.065417v1, 2006; 10.1373/clinchem.2005.065417
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
clinchem.2005.065417v1
52/8/1552    most recent
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Krayenbuehl, P.-A.
Right arrow Articles by Schulthess, G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Krayenbuehl, P.-A.
Right arrow Articles by Schulthess, G.

Received on December 19, 2005
Accepted on May 31, 2006

Molecular Diagnostics and Genetics

Tumor Necrosis Factor-{alpha} -308G>A Polymorphism Modulates Iron Accumulation in Patients with Hereditary Hemochromatosis

Pierre-Alexandre Krayenbuehl 1, Friedrich E. Maly 2, Martin Hersberger 2, Peter Wiesli 1, Andreas Himmelmann 1, Karim Eid 3, Peter Greminger 1, Wilhelm Vetter 1, Georg Schulthess 1*

1 Medical Policlinic, Department of Internal Medicine;
2 Institute of Clinical Chemistry;
3 Department of Surgery, University Hospital of Zurich Switzerland

* To whom correspondence should be addressed. E-mail: georg.schulthess{at}usz.ch.

Background: In vitro and animal studies suggest that tumor necrosis factor {alpha} (TNF-{alpha}) modulates intestinal iron transport. We hypothesized that the effect of TNF-{alpha} might be particularly relevant if iron absorption is not effectively controlled by the HFE system.

Methods: In patients with homozygous C282Y hemochromatosis, we investigated the influence of TNF-{alpha} -308G> polymorphism on total body iron overload, determined in all patients by measuring iron removed during depletion therapy, and hepatic iron index and need for phlebotomy to prevent iron reaccumulation, measured in patient subgroups.

Results: Of 86 patients with hereditary hemochromatosis, 16 (19%) were heterozygous carriers and 1 (1%) was a homozygous carrier of the TNF-{alpha} promoter -308A allele. Mean (SD) total body iron overload was increased 2-fold in TNF-{alpha} -308A allele carriers [10.9 (7.6) g] compared with homozygous carriers of the G allele [5.6 (5.0) g, P <0.001]. Hepatic iron index differed markedly between TNF-{alpha} -308A allele carriers [5.6 (3.5) µmol/g/year] and homozygous G allele carriers [3.1 (2.2) µmol/g/year, P = 0.040, n = 30]. After iron depletion, the need for phlebotomy to prevent iron reaccumulation (maintenance therapy) was substantially higher in TNF-{alpha} -308A allele carriers than in homozygous G allele carriers (P = 0.014, n = 73). We used multiple regression analyses to exclude possible confounding effects of sex, age, family screening, body-mass index, and meat or alcohol intake.

Conclusion: TNF-{alpha} -308G>A polymorphism modulates iron accumulation in patients with hereditary (homozygous C282Y) hemochromatosis, but the effect of the TNF-{alpha} -308A allele on clinical manifestations of hemochromatosis was less accentuated than expected from the increased iron load associated with this allele.




The following articles in journals at HighWire Press have cited this article:


Home page
BloodHome page
S. H. Atkinson, K. A. Rockett, G. Morgan, P. A. Bejon, G. Sirugo, M. A. O'Connell, N. Hanchard, D. P. Kwiatkowski, and A. M. Prentice
Tumor necrosis factor SNP haplotypes are associated with iron deficiency anemia in West African children
Blood, November 15, 2008; 112(10): 4276 - 4283.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Copyright © 2006 by the American Association for Clinical Chemistry.